These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 16550578)

  • 1. Isolated lung perfusion with melphalan: pharmacokinetics and toxicity in a pig model.
    van der Elst A; Oosterling SJ; Paul MA; Vonk AM; Sparidans RW; van der Sijp JR
    J Surg Oncol; 2006 Apr; 93(5):410-6. PubMed ID: 16550578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of isolated lung perfusion with melphalan for resectable pulmonary metastases, a phase I and extension trial.
    Grootenboers MJ; Hendriks JM; van Boven WJ; Knibbe CA; van Putte B; Stockman B; De Bruijn E; Vermorken JB; Van Schil PE; Schramel FM
    J Surg Oncol; 2007 Dec; 96(7):583-9. PubMed ID: 17999399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional differences of melphalan lung levels after isolated lung perfusion in the rat.
    Romijn S; Hendriks JM; Van Putte BP; Weyler J; Guetens G; De Boeck G; Van Schil PE
    J Surg Res; 2005 May; 125(2):157-60. PubMed ID: 15854668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long-term evaluation of pulmonary toxicity following isolated lung perfusion with melphalan in the rat.
    Ueda K; Sugi K; Li TS; Saeki K; Nawata S; Esato K
    Anticancer Res; 1999; 19(1A):141-7. PubMed ID: 10226535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of isolated lung perfusion as neoadjuvant therapy of lung metastases using a novel in vivo pig model: II. High-dose cisplatin is well tolerated by the native lung tissue.
    Franke UF; Wittwer T; Kaluza M; Albert M; Becker V; Roskos M; Lessel M; Wahlers T
    Eur J Cardiothorac Surg; 2004 Oct; 26(4):800-6. PubMed ID: 15450576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolated lung perfusion with melphalan for resectable lung metastases: a phase I clinical trial.
    Hendriks JM; Grootenboers MJ; Schramel FM; van Boven WJ; Stockman B; Seldenrijk CA; ten Broecke P; Knibbe CA; Slee P; De Bruijn E; Vlaeminck R; Heeren J; Vermorken JB; van Putte B; Romijn S; Van Marck E; Van Schil PE
    Ann Thorac Surg; 2004 Dec; 78(6):1919-26; discussion 1926-7. PubMed ID: 15561001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated lung perfusion for the treatment of pulmonary metastases an experimental study in the rat.
    Van Schil P; Hendriks J
    Verh K Acad Geneeskd Belg; 1999; 61(4):517-50. PubMed ID: 10500475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective pulmonary artery perfusion with melphalan is equal to isolated lung perfusion but superior to intravenous melphalan for the treatment of sarcoma lung metastases in a rodent model.
    Den Hengst WA; Hendriks JM; Van Hoof T; Heytens K; Guetens G; de Boeck G; Lardon F; Van Schil PE
    Eur J Cardiothorac Surg; 2012 Aug; 42(2):341-7; discussion 347. PubMed ID: 22345285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeat isolated limb perfusion with TNFalpha and melphalan for recurrent limb melanoma after failure of previous perfusion.
    Noorda EM; Vrouenraets BC; Nieweg OE; van Geel AN; Eggermont AM; Kroon BB
    Eur J Surg Oncol; 2006 Apr; 32(3):318-24. PubMed ID: 16412605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated lung perfusion with melphalan for the treatment of metastatic pulmonary sarcoma.
    Nawata S; Abecasis N; Ross HM; Abolhoda A; Cheng H; Sachar KS; Burt ME
    J Thorac Cardiovasc Surg; 1996 Dec; 112(6):1542-7; discussion 1547-8. PubMed ID: 8975846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic antitumor activity of histamine plus melphalan in isolated limb perfusion: preclinical studies.
    Brunstein F; Hoving S; Seynhaeve AL; van Tiel ST; Guetens G; de Bruijn EA; Eggermont AM; ten Hagen TL
    J Natl Cancer Inst; 2004 Nov; 96(21):1603-10. PubMed ID: 15523089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Video-assisted transcatheter lung perfusion regional chemotherapy.
    Jinbo M; Ueda K; Kaneda Y; Sudo M; Li TS; Hamano K
    Eur J Cardiothorac Surg; 2005 Jun; 27(6):1079-82. PubMed ID: 15896621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF-based isolated limb perfusion in unresectable extremity desmoid tumours.
    Grünhagen DJ; de Wilt JH; Verhoef C; van Geel AN; Eggermont AM
    Eur J Surg Oncol; 2005 Oct; 31(8):912-6. PubMed ID: 16098709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of beta-catenin by antisense oligomers augments tumor response to isolated limb perfusion in a rodent model of adenomatous polyposis coli-mutant colon cancer.
    Canter RJ; Kesmodel SB; Heitjan DF; Veeramachaneni NK; Mokadam NA; Drebin JA; Fraker DL
    Ann Surg Oncol; 2005 Sep; 12(9):733-42. PubMed ID: 16132380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic antitumor response of interleukin 2 with melphalan in isolated limb perfusion in soft tissue sarcoma-bearing rats.
    Hoving S; Brunstein F; aan de Wiel-Ambagtsheer G; van Tiel ST; de Boeck G; de Bruijn EA; Eggermont AM; ten Hagen TL
    Cancer Res; 2005 May; 65(10):4300-8. PubMed ID: 15899822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-evaluation of toxicity and long-term follow-up of isolated lung perfusion with melphalan in patients with resectable pulmonary metastases: a phase I and extension trial.
    Grootenboers MJ; Schramel FM; van Boven WJ; van Putte BP; Hendriks JM; Van Schil PE
    Ann Thorac Surg; 2007 Mar; 83(3):1235-6. PubMed ID: 17307516
    [No Abstract]   [Full Text] [Related]  

  • 17. Isolated limb perfusion with melphalan for femoral metastases of breast cancer: case report.
    Noorda EM; Vrouenraets BC; Nieweg OE; Pinedo HM; Kroon BB
    J Surg Oncol; 2002 Dec; 81(4):209-12. PubMed ID: 12451626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of repeat isolated limb perfusions with tumor necrosis factor alpha and melphalan for multiple in-transit metastases in patients with prior isolated limb perfusion failure.
    Grünhagen DJ; van Etten B; Brunstein F; Graveland WJ; van Geel AN; de Wilt JH; Eggermont AM
    Ann Surg Oncol; 2005 Aug; 12(8):609-15. PubMed ID: 15968498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of severe systemic toxicity after leakage-controlled isolated limb perfusion with tumor necrosis factor-alpha and melphalan.
    Vrouenraets BC; Kroon BB; Ogilvie AC; van Geel AN; Nieweg OE; Swaak AJ; Eggermont AM
    Ann Surg Oncol; 1999 Jun; 6(4):405-12. PubMed ID: 10379864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A human melanoma xenograft in a nude rat responds to isolated limb perfusion with TNF plus melphalan.
    Bauer TW; Gutierrez M; Dudrick DJ; Li J; Blair IA; Menon C; Fraker DL
    Surgery; 2003 Apr; 133(4):420-8. PubMed ID: 12717360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.